A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT07321951 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07321951
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-09
- Primary completion
- 2027-06-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.